1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseasesinterstitial lung disease, lung disorder, respiratory system disorderRecruitingPhase 2 / Phase 32024-11-19NCT06440746